Document is current
Any future updates will be listed below
-
Authors
,
Kotecha, Dipak https://orcid.org/0000-0002-2570-9812
Flather, Marcus D.
Atar, Dan
Collins, Peter
Pepper, John
Jenkins, Elizabeth
Reid, Christopher M.
Eccleston, David
-
Funding
Funding for this research was provided by:
IM Medical Ltd (n/a)
Research Trainees Coordinating Centre (CDF-2015-08-074)
- License Information
-
More Information
Article History
Received: 21 December 2018
Accepted: 13 March 2019
First Online: 3 April 2019
Ethics approval and consent to participate
: The ARM-CAD Study was approved by Ethics Committees from Monash University, Melbourne, Australia (2006/831MC) and The Alfred Melbourne, Australia (38/07).All patients provided written informed consent.
: Not applicable – all original data.
: MDF reports grants from Novartis and personal fees from AstraZeneca, Novartis and Pfizer, all outside the submitted work. DA has received speakers’ honoraria from Roche Diagnostics and Siemens Diagnostics, outside the submitted work. PC reports personal speaking honoraria from Menarini, AstraZenica, Bayer, Itamar Medical, Abbott and Ferring Pharmaceuticals, all outside the submitted work. The other authors declare that they have no competing interests.
: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
